Knowledge Center

Patent / Sep 30, 2021

Compositions for use in treating meibomian gland dysfunction

Authors:
  • Carla Vozone
  • Mohammad Salman
  • George Magrath
  • Courtney Smith
Source:
WO 2021191273

The invention provides methods, compositions, and kits containing a minocycline topical suspension, for treating meibomian gland dysfunction and related disorders.

Also in the Knowledge Center

Related Content

Inspections History

Hovione sites are periodically inspected by the local and external authorities. All sites are FDA approved and with exception of New Jersey site all have EU GMP certificates.

Page
Read more

Speak Up!

An Ethics Line to enable team members to Speak Up!

Page
Read more

Drug delivery platforms

Hovione has unique capabilities and expertise in solubility enhancement, lung delivery, modified release and taste-masking applications.

Page
Read more